PharmaShots Weekly Snapshot (July 15– 19, 2019)
1.Gilead Signs an Exclusive Worldwide License Agreement with Novartis for its Three Preclinical Antiviral Programs
Published: Jul 19, 2019 | Tags: Gilead, Signs, Exclusive, Worldwide, License, Agreement, Novartis, Three, Preclinical, Antiviral, Programs
Published: Jul 18, 2019 | Tags: Amgen, Allergan, Report, Availability, Mvasi, biosimilar, bevacizumab, Kanjinti, trastuzumab, the US
Published: Jul 18, 2019 | Tags: Mallinckrodt, Signs, Agreement, Silence Therapeutics, Develop, Commercialize, RNAi, Therapeutics, Complement-Mediated Diseases
Published: Jul 18, 2019 | Tags: Boehringer Ingelheim, Reports, Results, Ofev, nintedanib, INMARK Study, Patients, Idiopathic Pulmonary Fibrosis, IPF
Published: Jul 18, 2019 | Tags: Boehringer Ingelheim, Signs, Worldwide, License, Agreement, Bridge Biotherapeutics, Autotaxin, Inhibitor BBT-877
Published: Jul 18, 2019 | Tags: Interpace Diagnostics, Signs, AI-Driven, Agreement, Predictive Oncology, Diagnosing, Thyroid Cancer
7. Takeda and Chembio Diagnostics Collaborate to Develop Point-of-Care Diagnostic Test
Published: Jul 18, 2019 | Tags:Takeda, Chembio Diagnostics, Collaborate, Develop, Point-of-Care, Diagnostic Test
Published: Jul 17, 2019 | Tags: Astellas, Signs, License, Agreement, Frequency Therapeutics, Develop, Commercialize, FX-322, Hearing Loss
Published: Jul 18, 2019 | Tags: Bayer, BMS, Ono, Sign, Clinical Agreement, Evaluate, Dual Regimen, Metastatic Colorectal Cancer
10.Paragon Biosciences Launches a Facility for the Advancement of QuantX Medical Imaging AI System Diagnosing Breast Cancer
Published: Jul 17, 2019 | Tags: Paragon Biosciences, Launches, Qlarity Imaging, Advance, QuantX, Medical Imaging, AI system, Diagnose, Breast Cancer
Published: Jul 17, 2019 | Tags: Novartis, Kisqali, ribociclib, Fulvestrant, Receive, NICE, Approval, Advanced, Metastatic, Breast Cancer
12. MacroGenics Plans to Advance the Development of Flotetuzumab for Acute Myeloid Leukemia
Published: Jul 17, 2019 | Tags: MacroGenics, Plans, Advance, Development, Flotetuzumab, Acute Myeloid Leukemia
Published: Jul 16, 2019 | Tags: Genentech, Signs, Research, License, Agreement, Sosei Heptares, Develop, GPCR, Modulating Therapies
Published: Jul 17, 2019 | Tags: Allergan, Reports, FDA, Acceptance, NDA, Bimatoprost, Sustained Release, Treat, Glaucoma, Ocular Hypertension
15. Merck’s Recarbrio (imipenem/cilastatin/relebactam) Receives the US FDA’s Approval for Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
Published: Jul 17, 2019 | Tags: Merck, Recarbrio, imipenem, cilastatin, relebactam, Receives, US FDA, Approval, Complicated Urinary Tract, Complicated Intra-Abdominal Bacterial Infections
16. Knight Therapeutics’ Nerlynx (neratinib) Receives Health Canada Approval as Extended Adjuvant Therapy for HR+ and HER2+ Breast Cancer
Published: Jul 16, 2019 | Tags: Knight Therapeutics, Nerlynx, neratinib, Receives, Health Canada, Approval, Extended Adjuvant Therapy, HR, HER2, Positive, Breast Cancer
Published: Jul 16, 2019 | Tags: Genentech, Enters, Exclusive, Worldwide, Collaboration, Option, Acquire, Agreement, Convelo, Discover, Remyelinating Therapies
Published: Jul 16, 2019 | Tags: Genentech, Signs, Exclusive, Option, License, Agreement, Skyhawk, Discover, Develop, RNA, Splicing, Modifiers, Oncology, Neurodegenerative, Diseases
19. Novartis Reports FDA’s Acceptance of BLA for Crizanlizumab (SEG101) to Treat Sickle Cell Disease
Published: Jul 16, 2019 | Tags: Novartis, Reports, FDA, Acceptance, BLA, Crizanlizumab, SEG101, Sickle Cell Disease
Published: Jul 16, 2019 | Tags: T-CiRA, Research. Collaboration, Initiates, Clinical Study, iCART, Therapies, Treatment, Cancer
Published: Jul 15, 2019 | Tags: Bayer, Gadavist, gadobutrol, Injection, Receives, US, FDA, Approval, CMRI, Coronary Artery Disease
22. Abbott’s MitraClip G4 Receives the US FDA’s Approval for the Treatment of Mitral Regurgitation
Published: June 15, 2019 | Tags: Abbott, MitraClip G4, Receives, US, FDA, Approval, Treatment, Mitral Regurgitation
23. Boehringer Ingelheim Acquires AMAL Therapeutics for its KISIMA Immunization Platform
Published: Jul 15, 2019 | Tags: Boehringer Ingelheim, Acquires, AMAL Therapeutics, KISIMA, Immunization Platform
24. AbbVie Acquires Mavupharma for its STING (STimulator of INterferon Genes) Modulators to Treat Cancer
Published: Jul 15, 2019 | Tags: AbbVie, Acquires, Mavupharma, STING, STimulator of INterferon Genes, Modulators, Treat Cancer
Published: Jul 12, 2019 | Tags: Janssen, Reports, Submission, BLA, US FDA, Darzalex, daratumumab, Subcutaneous Formulation, Multiple Myeloma
26. Gilead to Raise Stake in Galapagos with ~$5.1B Deal
Published: Jul 14, 2019 | Tags: Gilead, Raise, Stake, Galapagos, $5.1B Deal
Published: Jul 15, 2019 | Tags: GSK, Reports, Results, Zejula, niraparib, P-III, PRIMA, Study, 1L, Maintenance, Therapy, Ovarian, Cancer